138 related articles for article (PubMed ID: 20193114)
1. Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma.
Gan SY; Zhong XY; Xie SM; Li SM; Peng H; Luo F
Chin J Cancer; 2010 Mar; 29(3):300-5. PubMed ID: 20193114
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
Peng H; Zhong XY; Liu KP; Li SM
Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
[TBL] [Abstract][Full Text] [Related]
3. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
[TBL] [Abstract][Full Text] [Related]
4. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 affects tumor drug resistance in esophageal squamous cell carcinoma by regulating expressions of P-gp and MRP1.
Zhang S; Cao W; Yue M; Zheng N; Hu T; Yang S; Dong Z; Lu S; Mo S
Tumour Biol; 2016 Jul; 37(7):9189-96. PubMed ID: 26768616
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma.
Wang W; Xue L; Wang P
Med Oncol; 2011 Mar; 28(1):163-9. PubMed ID: 20143187
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
Lee YK; Lin TH; Chang CF; Lo YL
PLoS One; 2013; 8(11):e82478. PubMed ID: 24303084
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
9. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
[TBL] [Abstract][Full Text] [Related]
10. NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression.
Chen J; Yang H; Wen J; Luo K; Liu Q; Huang Y; Zheng Y; Tan Z; Huang Q; Fu J
Oncotarget; 2015 May; 6(14):12405-20. PubMed ID: 25915159
[TBL] [Abstract][Full Text] [Related]
11. Association of Wnt1/beta-catenin with clinical pathological characteristics and prognosis of esophageal squamous cell carcinoma.
Lv J; Cao XF; Ji L; Zhu B; Tao L; Wang DD
Genet Test Mol Biomarkers; 2010 Jun; 14(3):363-9. PubMed ID: 20491588
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
13. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
[TBL] [Abstract][Full Text] [Related]
14. Activating transcription factor 4 mediates a multidrug resistance phenotype of esophageal squamous cell carcinoma cells through transactivation of STAT3 expression.
Zhu H; Chen X; Chen B; Chen B; Fan J; Song W; Xie Z; Jiang D; Li Q; Zhou M; Sun D; Zhao Y
Cancer Lett; 2014 Nov; 354(1):142-52. PubMed ID: 25130172
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic HDPR1 is involved in regional lymph node metastasis and tumor development via beta-catenin accumulation in esophageal squamous cell carcinoma.
Hou J; Li EM; Shen JH; Qing-Zhao ; Wu ZY; Xu XE; Wu JY; Qiao-Huang ; Shen J; Guo MZ; Xu LY
J Histochem Cytochem; 2011 Jul; 59(7):711-8. PubMed ID: 21525190
[TBL] [Abstract][Full Text] [Related]
16. Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.
Yamasaki M; Makino T; Masuzawa T; Kurokawa Y; Miyata H; Takiguchi S; Nakajima K; Fujiwara Y; Matsuura N; Mori M; Doki Y
Br J Cancer; 2011 Feb; 104(4):707-13. PubMed ID: 21206495
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma.
Li X; Suo J; Shao S; Xue L; Chen W; Dong L; Shi J; Fu M; Lu N; Zhan Q; Tong T
PLoS One; 2014; 9(3):e90958. PubMed ID: 24608342
[TBL] [Abstract][Full Text] [Related]
18. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
Deng F; Zhou K; Cui W; Liu D; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
[TBL] [Abstract][Full Text] [Related]
20. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
